.jpg)
.jpg)
Barnes & Noble Shares Soar After Investor Discusses Sale with Founder
07 Sep, 2018
BioXcel Therapeutics Announces Fourth Quarter and Fiscal Year 2019 Earnings
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) reported fourth quarter and full year ended December 31st, 2019 financial results. BXCL501 is designed for the treatment of acute agitation. The company initiated phase 3 trials for acute tr..
@Newsletter
Sign Up for Weekly UpdatesOpt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!
No articles found.
.jpg){kind=small}
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).